
Dewanda A. Samuel
Examiner (ID: 3769, Phone: (571)270-1213 , Office: P/2464 )
| Most Active Art Unit | 2464 |
| Art Unit(s) | 2616, 2416, 2464 |
| Total Applications | 590 |
| Issued Applications | 495 |
| Pending Applications | 2 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14501911
[patent_doc_number] => 20190194610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => METHODS AND COMPOSITIONS FOR IN VIVO TRANSGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/178696
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178696 | METHODS AND COMPOSITIONS FOR IN VIVO TRANSGENESIS | Nov 1, 2018 | Abandoned |
Array
(
[id] => 14462927
[patent_doc_number] => 20190183102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => NEW ALZHEIMER'S DISEASE ANIMAL MODEL
[patent_app_type] => utility
[patent_app_number] => 16/178949
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178949 | Alzheimer's disease animal model | Nov 1, 2018 | Issued |
Array
(
[id] => 19166037
[patent_doc_number] => 11981927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Method for producing liver stem cells or liver progenitor cells by direct reprogramming
[patent_app_type] => utility
[patent_app_number] => 16/757817
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5595
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757817 | Method for producing liver stem cells or liver progenitor cells by direct reprogramming | Oct 22, 2018 | Issued |
Array
(
[id] => 17285909
[patent_doc_number] => 11202444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Red transgenic fluorescent ornamental fish
[patent_app_type] => utility
[patent_app_number] => 16/160586
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2843
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160586 | Red transgenic fluorescent ornamental fish | Oct 14, 2018 | Issued |
Array
(
[id] => 17251371
[patent_doc_number] => 11186848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Non-human animals expressing humanized C1Q complex
[patent_app_type] => utility
[patent_app_number] => 16/144156
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31951
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144156 | Non-human animals expressing humanized C1Q complex | Sep 26, 2018 | Issued |
Array
(
[id] => 16174705
[patent_doc_number] => 20200221673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => AQUACULTURED CRUSTACEAN AND METHOD OF PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/648514
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648514 | Aquacultured crustacean and method of producing same | Sep 24, 2018 | Issued |
Array
(
[id] => 16283966
[patent_doc_number] => 20200277568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => Small Molecule-Induced Method for Directly Reprogramming Human Fibroblasts into Liver Cells
[patent_app_type] => utility
[patent_app_number] => 16/645819
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645819
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645819 | Small Molecule-Induced Method for Directly Reprogramming Human Fibroblasts into Liver Cells | Sep 16, 2018 | Abandoned |
Array
(
[id] => 14067553
[patent_doc_number] => 20190082664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => HUMANIZED MOUSE MODEL FOR CANCER METASTASIS
[patent_app_type] => utility
[patent_app_number] => 16/131256
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131256 | HUMANIZED MOUSE MODEL FOR CANCER METASTASIS | Sep 13, 2018 | Abandoned |
Array
(
[id] => 13607527
[patent_doc_number] => 20180355313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => PLURIPOTENT STEM CELL THAT CAN BE ISOLATED FROM BODY TISSUE
[patent_app_type] => utility
[patent_app_number] => 16/104224
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104224 | PLURIPOTENT STEM CELL THAT CAN BE ISOLATED FROM BODY TISSUE | Aug 16, 2018 | Pending |
Array
(
[id] => 14852609
[patent_doc_number] => 10415018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Method for screening for pluripotent stem cell growth-promoting factor
[patent_app_type] => utility
[patent_app_number] => 16/053583
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8920
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16053583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/053583 | Method for screening for pluripotent stem cell growth-promoting factor | Aug 1, 2018 | Issued |
Array
(
[id] => 13522541
[patent_doc_number] => 20180312813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METHOD FOR REJUVENATING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/028532
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028532 | METHOD FOR REJUVENATING CELLS | Jul 5, 2018 | Abandoned |
Array
(
[id] => 17392472
[patent_doc_number] => 11241460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 16/025788
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 65
[patent_no_of_words] => 35792
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025788
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025788 | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells | Jul 1, 2018 | Issued |
Array
(
[id] => 15130049
[patent_doc_number] => 10478461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Cellular extracts
[patent_app_type] => utility
[patent_app_number] => 16/011134
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 47925
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011134 | Cellular extracts | Jun 17, 2018 | Issued |
Array
(
[id] => 13777957
[patent_doc_number] => 20190002517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => NEUROPEPTIDE Y-DERIVED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/007681
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16007681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/007681 | NEUROPEPTIDE Y-DERIVED PEPTIDES | Jun 12, 2018 | Abandoned |
Array
(
[id] => 17620330
[patent_doc_number] => 11339369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Production of parthenogenetic stem cells and patient-specific human embryonic stem cells using somatic cell nuclear transfer
[patent_app_type] => utility
[patent_app_number] => 16/001781
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17495
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/001781 | Production of parthenogenetic stem cells and patient-specific human embryonic stem cells using somatic cell nuclear transfer | Jun 5, 2018 | Issued |
Array
(
[id] => 13439057
[patent_doc_number] => 20180271071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => HUMANIZED IL-6 AND IL-6 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/001074
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16001074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/001074 | Humanized IL-6 and IL-6 receptor | Jun 5, 2018 | Issued |
Array
(
[id] => 13428611
[patent_doc_number] => 20180265848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => RNA PREPARATIONS COMPRISING PURIFIED MODIFIED RNA FOR REPROGRAMMING CELLS
[patent_app_type] => utility
[patent_app_number] => 15/994093
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994093 | RNA preparations comprising purified modified RNA for reprogramming cells | May 30, 2018 | Issued |
Array
(
[id] => 16839792
[patent_doc_number] => 20210147804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD FOR EXPANDING STEMNESS AND DIFFERENTIATION POTENTIAL OF PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 16/616892
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616892 | Method for expanding stemness and differentiation potential of pluripotent cells | May 24, 2018 | Issued |
Array
(
[id] => 17975794
[patent_doc_number] => 11492644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Genetically induced nephron progenitors
[patent_app_type] => utility
[patent_app_number] => 16/616229
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 22968
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616229 | Genetically induced nephron progenitors | May 23, 2018 | Issued |
Array
(
[id] => 13428041
[patent_doc_number] => 20180265563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => Consumable Cryopreserved Cells Transiently Overexpressing Gene(s) Encoding Drug Transporter Protein(s) and/or Drug Metabolizing Enzyme(s)
[patent_app_type] => utility
[patent_app_number] => 15/988819
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988819
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988819 | Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s) | May 23, 2018 | Issued |